l-Tryptophan-Induced Vasodilation Is Enhanced in Preeclampsia: Studies on Its Uptake and Metabolism in the Human Placenta.
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
/ pharmacology
Adult
Arteries
/ metabolism
Carrier Proteins
/ biosynthesis
Cytokines
/ pharmacology
Enzyme Induction
/ drug effects
Female
Humans
Indoleamine-Pyrrole 2,3,-Dioxygenase
/ drug effects
Kynurenine
/ metabolism
Maternal-Fetal Exchange
Nitric Oxide
/ metabolism
Nitric Oxide Synthase
/ antagonists & inhibitors
Placenta
/ blood supply
Pre-Eclampsia
/ enzymology
Pregnancy
RNA, Messenger
/ biosynthesis
Tryptophan
/ analogs & derivatives
Vasodilation
/ drug effects
kynurenine pathway
placenta
pregnancy
tryptophan
vasodilation
Journal
Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
pubmed:
2
6
2020
medline:
14
4
2021
entrez:
2
6
2020
Statut:
ppublish
Résumé
l-tryptophan induces IDO (indoleamine 2,3-dioxygenase) 1-dependent vasodilation. IDO1 is expressed in placental endothelial cells and downregulated in preeclampsia. Hypothesizing that this may contribute to diminished placental perfusion, we studied l-tryptophan-induced vasodilation in healthy and early-onset preeclampsia placental arteries, focusing on placental kynurenine pathway alterations. Despite IDO1 downregulation, kynurenine pathway metabolite concentrations (measured with ultra-performance liquid chromatography-tandem mass spectrometry) were unaltered in preeclamptic versus healthy placentas. Most likely, this is due to enhanced l-tryptophan uptake, evidenced by increased l-tryptophan levels in preeclamptic placentas. Ex vivo perfused cotyledons from healthy and preeclamptic placentas released similar amounts of l-tryptophan and kynurenine pathway metabolites into the circulations. This release was not altered by adding l-tryptophan in the maternal circulation, suggesting that l-tryptophan metabolites act intracellularly. Maternally applied l-tryptophan did appear in the fetal circulation, confirming placental passage of this essential amino acid. After in vitro incubation of placental arteries with IDO1-upregulating cytokines interferon-γ and tumor necrosis factor-α, l-tryptophan induced vasodilation. This vasodilation was attenuated by both IDO1 and nitric oxide (NO) synthase inhibitors. Despite IDO1 downregulation, l-tryptophan-induced relaxation was enhanced in preeclamptic versus healthy placental arteries. However, cytokine stimulation additionally upregulated the LAT (l-type amino acid transporter) 1 in preeclamptic placental arteries only. Vasodilation to the lipophilic, transporter independent ethyl ester of l-tryptophan was reduced in preeclamptic versus healthy placental arteries, in agreement with reduced IDO1 expression. In conclusion, l-tryptophan induces IDO1- and NO-dependent relaxation in placental arteries, which is determined by l-tryptophan uptake rather than IDO1 expression. Increased l-tryptophan uptake might compensate for reduced IDO1 expression in preeclamptic placentas.
Identifiants
pubmed: 32475317
doi: 10.1161/HYPERTENSIONAHA.120.14970
doi:
Substances chimiques
Carrier Proteins
0
Cytokines
0
IDO1 protein, human
0
Indoleamine-Pyrrole 2,3,-Dioxygenase
0
RNA, Messenger
0
Nitric Oxide
31C4KY9ESH
Kynurenine
343-65-7
tryptophan ethyl ester
6519-66-0
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
76898-47-0
Tryptophan
8DUH1N11BX
Nitric Oxide Synthase
EC 1.14.13.39
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM